4-Nitro-7-(piperidin-1-yl)benzo[c][1,2,5]oxadiazole CAS 18378-22-8

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including 4-Nitro-7-(piperidin-1-yl)benzo[c][1,2,5]oxadiazole.

4-Nitro-7-(piperidin-1-yl)benzo[c][1,2,5]oxadiazole (CAS 18378-22-8), molecular formula C11H12N4O3 and molecular weight 248.24 g/mol, is a CATO reference standard with documented purity and traceability.

The molecular framework of 4-Nitro-7-(piperidin-1-yl)benzo[c][1,2,5]oxadiazole (C11H12N4O3) is characterized by an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

CATO manufactures 4-Nitro-7-(piperidin-1-yl)benzo[c][1,2,5]oxadiazole under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com